Search This Blog

Friday, August 30, 2024

HUTCHMED pulls China submission for Takeda-partnered drug

 HUTCHMED (HCM) stock on watch as company withdraws marketing application for anti-cancer drug in China marketed with Takeda

https://seekingalpha.com/news/4145435-hutchmed-pulls-china-submission-takeda-partnered-drug

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.